Private clinics have been prohibited from prescribing puberty blockers to gender-confused young people in Great Britain. Until 3 September, new patients under 18 years old will no longer be able to obtain the experimental drugs via private prescriptions from the UK or Europe. The ban will prevent the clinic from continuing to circumvent UK regulations by issuing prescriptions via Europe. ‘Dangerous’GenderGP has recently been accused of issuing a “dangerously high” dose of cross-sex hormones to a 15-year-old girl with autism. Judge Sir Andrew McFarlane found that GenderGP did not consult a doctor before issuing cross-sex hormones, and urged other courts to proceed with “extreme caution” before approving its practices.
